You are here

  • Home
  • Archive
  • Volume 102, Issue 1
  • In vitro synergy of natamycin and voriconazole against clinical isolates of Fusarium, Candida, Aspergillus and Curvularia spp

Article metrics

Article menu
Download PDFPDF
Laboratory science
In vitro synergy of natamycin and voriconazole against clinical isolates of Fusarium, Candida, Aspergillus and Curvularia spp

 

Online download statistics by month:

Online download statistics by month: October 2017 to March 2024

AbstractFullPdf
Oct 20174752620
Nov 2017233135
Dec 20173826626
Jan 20185267247
Feb 2018176255
Mar 2018125299
Apr 201882166
May 2018113146
Jun 2018118198
Jul 2018110208
Aug 201894274
Sep 201873184
Oct 201857113
Nov 2018101122
Dec 201877145
Jan 201974113
Feb 201962112
Mar 20194933
Apr 20194321
May 20194664
Jun 201941112
Jul 201956182
Aug 201957121
Sep 201958134
Oct 201984133
Nov 201946172
Dec 201939142
Jan 202041113
Feb 202052162
Mar 202080122
Apr 202053143
May 202057141
Jun 202049124
Jul 20203390
Aug 202040111
Sep 202063110
Oct 20206292
Nov 20202310
Dec 20207231
Jan 20213911
Feb 202111363
Mar 20215810
Apr 20212521
May 20212000
Jun 2021211
Aug 2021621
Sep 2021100
Oct 20214710
Nov 20214810
Dec 20213110
Jan 20226373
Feb 202294311
Mar 20224950
Apr 20224473
May 20227743
Jun 20226710
Jul 20226333
Aug 20226822
Sep 20226443
Oct 20224900
Nov 20224352
Dec 20223601
Jan 20233544
Feb 20237313
Mar 20235785
Apr 20232802
May 20234026
Jun 20231901
Jul 20235042
Aug 20233013
Sep 20234311
Oct 20234412
Nov 20233611
Dec 20233114
Jan 20249029
Feb 202419114
Mar 20242455
Total5748753296